Director · MAIA Biotechnology, Inc. · MAIA Biotechnology, Inc. — Stock Options
Side
BUY
Value
$78K
Shares
57.2K
Price
$1.36
Executed
Dec 22, 2025
Disclosed
Dec 23, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 22 executedDec 23, 2025 disclosed
MAIA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 7 prior trades recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Smith Stan filed this Form 4 reporting a open-market purchase of MAIA on Dec 22, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Smith Stancik:0001913199
Issuer
MAIA Biotechnology, Inc.cik:0001878313
Revision history · 0
No field has changed since this record was first ingested.
